Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
marc.feldmann@kennedy.ox.ac.uk

Research groups

Sir Marc Feldmann FRS

Emeritus Professor

Recent publications

If vaccines falter, broad-spectrum antivirals provide a global shield

DWEK RA. et al, (2026), The Lancet, 407, 25 - 26

25 years of biologic DMARDs in rheumatology.

Feldmann M. et al, (2023), Nat Rev Rheumatol, 19, 761 - 766

Anti-TNF (adalimumab) injection for the treatment of adults with frozen shoulder during the pain predominant stage protocol for a multi-centre, randomised, double blind, parallel group, feasibility trial.

Hopewell S. et al, (2022), NIHR Open Res, 2

Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300

Williams LM. et al, (2020), Proceedings of the National Academy of Sciences, 202004281 - 202004281

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed.

Feldmann M. et al, (2020), Lancet, 395, 1407 - 1409